A cancer researcher found guilty of misconduct has reached a settlement with the ORI that allows him to apply for federal research funding.
Advertisement
The Scientist
Most Recent
A researcher working for a US pharmaceutical company’s Scotland branch is sent to prison for falsifying safety test data on experimental drugs due for clinical trials.
Researchers are identifying distinctive brain activity patterns that can be used to monitor patients under anesthesia and assess consciousness in “vegetative” patients.
A newly developed drug, modeled after a bacteria-infecting virus, is less likely to become antibiotic resistant.
A new study blames the unreliable nature of some research in the field on underpowered statistical analyses.
Just the flavor of beer is enough to boost dopamine in brain areas related to reward—especially in men with alcoholic relatives.
Mutations tied to autism in mice lead to deficits in the signaling pathway activated by marijuana.
A former University of Washington researcher did commit misconduct 10 years ago, according to the Office of Research Integrity.
Starting in 2014, the federally funded initiative will seek to develop new technologies capable of mapping the activity in the human brain.
A Japanese newspaper claims that the pharma giant funded flawed research that revealed extra health benefits for one of its top-selling drugs.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
